Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8962209 | 0.79 | LMNA (0.48) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL1353365 | 0.78 | LMNA (0.37) | LMNA | |
| SCHEMBL8486388 | 0.77 | LMNA (0.47) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL9129884 | 0.76 | — | — | |
| SCHEMBL513994 | 0.76 | — | — | |
| SCHEMBL11103446 | 0.76 | LMNA (0.42) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| Ocimene SCHEMBL28249585 | 0.76 | LMNA (0.39) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| Ethylene SCHEMBL4704387 | 0.75 | LMNA (0.45) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL27813655 | 0.71 | — | — | |
| SCHEMBL1437686 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214644-A1 | PERFUME PRECURSOR | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-07-15 | — | — | US | claimed |
| EP-3689849-A1 | PERFUME PRECURSOR | Takasago International Corporation (JP) | 2020-08-05 | — | — | EP | claimed |
| CN-109642184-A | Product including plastic containers and composition of matter | 西姆莱斯有限公司 | 2019-04-16 | — | — | CN | claimed |
| US-20130216723-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | KING INDUSTRIES (US) | 2013-08-22 | — | — | US | claimed |
| EP-2203519-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | King Industries (US) | 2010-07-07 | — | — | EP | claimed |
| US-20090104363-A1 | Sulfonate esters as latent acid catalysts | KING INDUSTRIES | 2009-04-23 | — | — | US | claimed |
| WO-2009045466-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | KING INDUSTRIES (US) | 2009-04-09 | — | — | WO | claimed |
| US-5278314-A | N-Phenol-substituted benzotriazoles | CIBA-GEIGY CORPORATION (US) | 1994-01-11 | — | — | US | claimed |
| EP-0576527-A1 | 5-THIO-SUBSTITUTED BENZOTRIAZOLE UV-ABSORBERS AND STABILIZED COMPOSITIONS | Ciba SC Holding AG (CH) | 1994-01-05 | — | — | EP | claimed |
| WO-1992014718-A1 | 5-THIO-SUBSTITUTED BENZOTRIAZOLE UV-ABSORBERS AND STABILIZED COMPOSITIONS | CIBA-GEIGY AG (CH) | 1992-09-03 | — | — | WO | claimed |
| US-11802258-B2 | Perfume precursor | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-10-31 | — | — | US | disclosed |
| US-20210214644-A1 | PERFUME PRECURSOR | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| EP-3689849-A1 | PERFUME PRECURSOR | Takasago International Corporation (JP) | 2020-08-05 | — | — | EP | disclosed |
| CN-106456573-B | Functionalized 1, 3-benzenediols for treating hepatic encephalopathy and methods of use thereof | 康纳生物技术有限公司 | 2019-12-03 | — | — | CN | disclosed |
| CN-109642184-A | Product including plastic containers and composition of matter | 西姆莱斯有限公司 | 2019-04-16 | — | — | CN | disclosed |
| EP-0576527-A1 | 5-THIO-SUBSTITUTED BENZOTRIAZOLE UV-ABSORBERS AND STABILIZED COMPOSITIONS | Ciba SC Holding AG (CH) | 1994-01-05 | — | — | EP | disclosed |
| EP-0572554-A1 | 5-SULFONYL-SUBSTITUTED BENZOTRIAZOLE UV-ABSORBERS AND STABILIZED COMPOSITIONS | Ciba SC Holding AG (CH) | 1993-12-08 | — | — | EP | disclosed |
| WO-1992014718-A1 | 5-THIO-SUBSTITUTED BENZOTRIAZOLE UV-ABSORBERS AND STABILIZED COMPOSITIONS | CIBA-GEIGY AG (CH) | 1992-09-03 | — | — | WO | disclosed |
| WO-1992014717-A1 | 5-SULFONYL-SUBSTITUTED BENZOTRIAZOLE UV-ABSORBERS AND STABILIZED COMPOSITIONS | CIBA-GEIGY AG (CH) | 1992-09-03 | — | — | WO | disclosed |
| EP-0097127-A2 | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1983-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802258-B2 | Perfume precursor | CYP2E1, ADH1A, CYP1A1 | LMNA 3027/4885ALDH1A1 26/4885ALOX15 172/4885 |
| US-20210214644-A1 | PERFUME PRECURSOR | CYP2E1, ADH1A, CYP1A1 | LMNA 3027/4885ALDH1A1 26/4885ALOX15 172/4885 |
| US-20090104363-A1 | Sulfonate esters as latent acid catalysts | ORAI1, SARAF, NAPA | LMNA 306/4885ALDH1A1 3647/4885ALOX15 787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.